Skip to main content


Fig. 1 | BMC Cancer

Fig. 1

From: Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer

Fig. 1

The Kaplan–Meier curves for TTF, PFS, and OS. a The median time to treatment failure was 7.0 months (95 % CI 4.7–10.8 months). b The median progression-free survival time was 11.7 months (95 % CI 8.0–13.4 months). c The median overall survival time was 22.9 months (95 % CI 17.6–33.0 months)

Back to article page